USPTO serial 88336357
BREWING FUNDS THE CURE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 24, 2019
- Examiner
- PARKS, KIMBERLY L
- Law office
- Historical data usage
What this means
Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.
Need help with BREWING FUNDS THE CURE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
National Pediatric Cancer Foundation, Inc.
Tampa, FL
Other trademarks owned by National Pediatric Cancer Foundation, Inc.
National Pediatric Cancer Foundation, Inc.
Tampa, FL
Other trademarks owned by National Pediatric Cancer Foundation, Inc.
National Pediatric Cancer Foundation, Inc.
Tampa, FL
Other trademarks owned by National Pediatric Cancer Foundation, Inc.
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 036 | Charitable fundraising | ACTIVE | Aug 7, 2017 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by National Pediatric Cancer Foundation, Inc.
- Other trademarks owned by National Pediatric Cancer Foundation, Inc.
- Other trademarks owned by National Pediatric Cancer Foundation, Inc.
- Other trademarks in Class 036
- Similar marks named BREWING FUNDS THE CURE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 1, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 1, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 1, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 13, 2025 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Feb 13, 2025 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Feb 13, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Oct 4, 2024 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Sep 24, 2024 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Sep 24, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 9, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 9, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 9, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 19, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 4, 2019 | ALIE | ASSIGNED TO LIE | — |
| May 22, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 22, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 22, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 22, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 22, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 21, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 29, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 15, 2019 | NWAP | NEW APPLICATION ENTERED | — |